SCHEMBL227129

SCHEMBL227129

O=c1cccc(Br)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5393702 0.72
SCHEMBL8535240 0.71 NOTUM (0.68)
SCHEMBL8340218 0.70
SCHEMBL6932842 0.70
SCHEMBL7369068 0.67 NOTUM (0.67)
SCHEMBL6930696 0.67
SCHEMBL8246393 0.67
SCHEMBL218183 0.67
SCHEMBL595653 0.67
SCHEMBL1843023 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743445-A1 NOVEL HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS DNA POLYMERASE THETA INHIBITORS FOR THE PREVENTION OR TREATMENT OF CANCER Daewoong Pharmaceutical Co., Ltd. (KR) 2026-05-20 EP disclosed
CN-117024411-B Isoquinoline as HPK1 inhibitor 豪夫迈·罗氏有限公司 2026-05-19 CN disclosed
EP-4709720-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN Larkspur Biosciences, Inc. (US) 2026-03-18 EP disclosed
EP-4642782-A2 ALPHA-V-BETA-8 INTEGRIN INHIBITORS AND USES THEREOF Pliant Therapeutics, Inc. (US) 2025-11-05 EP disclosed
US-12448377-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-10-21 US disclosed
US-20250313572-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC (US) 2025-10-09 US disclosed
EP-4066893-B1 6,7,8,9-TETRAHYDRO-4H-QUINOLIZIN-4-ONE COMPOUND AS OREXIN TYPE 2 RECEPTOR AGONIST TAKEDA PHARMACEUTICALS CO (JP) 2025-07-30 EP disclosed
US-12291523-B2 LXR modulators with bicyclic core moiety ORSOBIO, INC. (US) 2025-05-06 US disclosed
WO-2025051157-A1 PYRIDINE-2(1H)-KETONE PRMT5-MTA INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 赛诺哈勃药业(成都)有限公司 2025-03-13 WO disclosed
US-20250049814-A1 5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2025-02-13 US disclosed
US-6211371-B1 REACTING AN ARYL ISONIRILE WITH AN ISOQUINOLIN-1-ONE COMPOUND UNIVERSITY OF PITTSBURGH 2001-04-03 US disclosed
WO-2000064876-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 WO disclosed
US-6034243-A Intermediates in the synthesis of (±)-camptothecin and related compounds and synthesis thereof UNIVERSITY OF PITTSBURGH (US) 2000-03-07 US disclosed
WO-1999001456-A1 SYNTHESIS OF AND INTERMEDIATES FOR CAMPTOTHECINS UNIVERSITY OF PITTSBURGH (US) 1999-01-14 WO disclosed
US-5840654-A COMBATING UNDESIRED PLANT GROWTH BY TREATING LOCUS WITH SPECIFIED HERBICIDE AMERICAN CYANAMID COMPANY (US) 1998-11-24 US disclosed
US-5744605-A ANNULATION; CYCLIZATION UNIVERSITY OF PITTSBURGH (US) 1998-04-28 US disclosed
EP-0690846-B1 HERBICIDAL HETEROCYCLIC-SUBSTITUTED PYRIDINES SHELL INT RESEARCH (NL) 1998-01-07 EP disclosed
CN-1122596-A Herbicidal heterocyclic-substituted pyridines SHELL INT RESEARCH (NL) 1996-05-15 CN disclosed
EP-0690846-A1 HERBICIDAL HETEROCYCLIC-SUBSTITUTED PYRIDINES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1996-01-10 EP disclosed
WO-1994022833-A1 HERBICIDAL HETEROCYCLIC-SUBSTITUTED PYRIDINES SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1994-10-13 WO disclosed